Effective September 1, the rebranding is an adoption of its principal deliverable ‘Care’, the company said. Except the name, Care Health Insurance’s founding management team, value-for-money products and the technology-driven servicing capabilities are all the same, it added.
Read More
A recent study has revealed how certain areas in hospitals contained more viruses and how an increasing number of healthcare workers themselves get infected with the deadly virus.
Read More
Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.
Read More
COVID-19 has opened the Pandora’s Box for players with the impact clearly visible on the functioning models and financial health.
Read More
The drug did not improve progression-free survival in previously untreated patients with BRAF V600 mutation-positive cutaneous melanoma, compared to Tafinlar + Mekinist alone, Novartis said.
Read More
In India, GRA and Dr. Reddy’s will look to distribute Avigan® through private healthcare providers opting for a premium quality drug. The initial supply will contain the original Avigan®, made in Japan.
Read More
E-pharmacies is a large market in India and the retail segment is a fragmented one, ripe for consolidation.
Read More
Dr Reddy's said Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19.
Read More
